The COVID-19 pandemic highlighted the importance of laboratory preparedness. Regular monitoring of diagnostic tools via external quality assessments (EQAs) is key to maintaining robust public

ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8 – 15 March 2025 and includes updates on respiratory virus epidemiology

There is currently significant respiratory virus activity in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly encouraged

This protocol presents an updated common methodology for estimating COVID-19 vaccine effectiveness (VE) using established health data registries in participating European Union (EU) and European

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 – 7 March 2025 and includes updates on cholera associated with

There is currently significant respiratory virus activity in the EU/EEA. The flu season is in full swing, and an RSV epidemic is ongoing. Individuals eligible

There is currently significant respiratory virus activity in the EU/EEA. The flu season is in full swing, and an RSV epidemic is ongoing. Individuals eligible

This report presents a description of COVID-19 vaccine coverage in the EU/EEA between 1 August 2024 and 17 January 2025, with some variation in dates

There is currently significant respiratory virus activity in the EU/EEA, with an intense influenza season and concurrent RSV epidemic. People eligible for vaccination are encouraged

There is currently significant respiratory virus activity in the EU/EEA, with an intense influenza season and concurrent RSV epidemic. People eligible for vaccination are encouraged

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 February and includes updates on Mpox, Shigella sonnei, chikungunya, SARS-CoV-2, Ebola,